Back to Authors

Viswanatha, David

Mayo Clinic

Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

Citations 23

The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDS
Alkharabsheh, Omar , Al‐Kali, Aref , Saadeh, Salwa , He, Rong , Viswanatha, David S., Greipp, Patricia T. , Reichard, Kaaren K. , Gangat, Naseema , Patnaik, Mrinal M. , Litzow, Mark R. , Nguyen, Phuong L., Viswanatha, David, Greipp, Patricia, Gangat, Naseema , Patnaik, Mrinal , Hogan, William, Litzow, Mark R. , Greipp, Patricia T , Shah, Meera , Hogan, William J. , Alkhateeb, Hassan B.

American Journal of Hematology | August 7, 2018 | Volume: 93 | Issue: 11 | Pages: No page available

10.1002/ajh.25239 Get It

Clinical spectrum and clonal evolution in germline syndromes with predisposition to myeloid neoplasms
Botero, Juliana Perez , Ho, Thanh P. , Kenderian, Saad S. , Gangat, Naseema , Tefferi, Ayalew , Abraham, Roshini S. , Nguyen, Phuong L., Oliveira, Jennifer L. , He, Rong , Chen, Dong , Viswanatha, David S., Rodriguez, Vilmarie , Khan, Shakila P. , Patnaik, Mrinal M. , Herrick, Jennifer L. , Perez Botero, Juliana , Viswanatha, David, Hogan, William J. , Kenderian, Saad Sirop , Chen, Dong

British Journal of Haematology | May 9, 2017 | Volume: 182 | Issue: 1 | Pages: 141-145

10.1111/bjh.14746 Get It